Article - 09/06/2009 We would gladly finance more biotechs For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…https://www.biooekonomie-bw.de/en/articles/news/we-would-gladly-finance-more-biotechs
Article - 09/06/2009 We would gladly finance more biotechs For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…https://www.gesundheitsindustrie-bw.de/en/article/news/we-would-gladly-finance-more-biotechs
Press release - 03/06/2009 Hohenstein Institute develops textile that releases medicinal gasses The Institute for Hygiene and Biotechnology (IHB) at Hohenstein has developed the first textile that can release medically effective gasses. The textile was developed at the IHB under the auspices of a broader research project. The textile will be used in future therapeutic applications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hohenstein-institute-develops-textile-that-releases-medicinal-gasses
Article - 03/06/2009 Quality management for biotech companies? What kind of permits and certification do young biotech companies need? Do particular requirements in the quality assurance of production processes based on initial permits still have to be taken into account 10 years after foundation? Ten years on, it may in fact be necessary to obtain different certificates that take external factors into account as well as changes in a company’s product and service portfolio. But what do ISO 9001, ISO 13485,…https://www.gesundheitsindustrie-bw.de/en/article/news/quality-management-for-biotech-companies
Article - 29/05/2009 ITV Denkendorf – Hi-tech think tank for textiles The Institute of Textile Technology and Process Engineering Denkendorf ITV Denkendorf is Germanys largest and oldest textile research centre. Research is carried out in specialised laboratories and technical centres covering the entire range of textiles from raw materials to the final product both in basic as well as applied research. https://www.biooekonomie-bw.de/en/articles/news/itv-denkendorf-hi-tech-think-tank-for-textiles
Article - 29/05/2009 ITV Denkendorf – Hi-tech think tank for textiles The Institute of Textile Technology and Process Engineering Denkendorf ITV Denkendorf is Germanys largest and oldest textile research centre. Research is carried out in specialised laboratories and technical centres covering the entire range of textiles from raw materials to the final product both in basic as well as applied research. https://www.gesundheitsindustrie-bw.de/en/article/news/itv-denkendorf-hi-tech-think-tank-for-textiles
Article - 28/05/2009 Renovation work in the brain Damaged nerves in the brain only grow together again with difficulty. Scar tissue develops at the site of injury rendering the outgrowth of new protrusions almost impossible. Dr. Matthias Kirsch and his team from the Institute of Anatomy and Cell Biology at the University of Freiburg are investigating the role of a signalling molecule that might one day make regeneration possible. This molecule, a cytokine of the interleukin-6 family, influences…https://www.gesundheitsindustrie-bw.de/en/article/news/renovation-work-in-the-brain
Press release - 28/05/2009 CureVac Begins Clinical Study with mRNA Vaccine CureVac GmbH announced that the Paul-Ehrlich-Institute, the German regulatory authority for medicinal products, has approved the Clinical Trial Application (CTA) to begin a Phase I clinical study with RNActive® derived mRNA vaccine CV9201. The vaccine will be tested in patients with advanced non-small cell lung cancer who have been pre-treated with different therapies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-begins-clinical-study-with-mrna-vaccine
Press release - 28/05/2009 CONCERT Medical Optics wins special CyberOne prize The company CONCERT Medical Optics was selected from more than 70 participants from all over Germany to receive a special CyberOne prize for the most innovative start-up concept namely a medical instrument called EndoTherapeuthoSkop. This instrument combines different technologies enabling the simultaneous detection and treatment of tumours meaning that patients only have to undergo one rather than several interventions.https://www.gesundheitsindustrie-bw.de/en/article/press-release/concert-medical-optics-wins-special-cyberone-prize
Article - 27/05/2009 Raimund Hibst brings laser into dental practices Nowadays, in many dental practices drills are no longer used to remove caries – much to the patients’ delight. Such practices have replaced drills with lasers, a virtually painless method, with low noise levels and which does not require a local anaesthetic. This is all thanks to the work of Raimund Hibst, a physicist from the ILM in Ulm who has spent many years turning research findings into health market applications, in cooperation with…https://www.gesundheitsindustrie-bw.de/en/article/news/raimund-hibst-brings-laser-into-dental-practices
Press release - 27/05/2009 REGiNA makes regenerative medicine standard practice in patient care German Federal Minister Annette Schavan announced BioRegio STERN Management GmbH a winner of the Gesundheitsregionen der Zukunft Health Regions of the Future competition on 27 May in Berlin. The German Federal Ministry of Education and Research BMBF will support the planned Users Centre for Regenerative Medicine in the Neckar-Alb and Stuttgart health region REGiNA for the next four years covering around half of the total budget of almost EUR 17…https://www.gesundheitsindustrie-bw.de/en/article/press-release/regina-makes-regenerative-medicine-standard-practice-in-patient-care
Dossier - 25/05/2009 The different phases of company foundation Founding a company is a very complex process especially in knowledge-intensive sectors such as biotechnology. Turning a vague business idea into a successful company is characterised by different phases that place great demands on the qualifications and learning aptitudes of the company founders. Financing and economic organisation often means that company founders have to enter completely unknown new territory.https://www.gesundheitsindustrie-bw.de/en/article/dossier/the-different-phases-of-company-foundation
Dossier - 25/05/2009 The different phases of company foundation Founding a company is a very complex process especially in knowledge-intensive sectors such as biotechnology. Turning a vague business idea into a successful company is characterised by different phases that place great demands on the qualifications and learning aptitudes of the company founders. Financing and economic organisation often means that company founders have to enter completely unknown new territory.https://www.biooekonomie-bw.de/en/articles/dossiers/the-different-phases-of-company-foundation
Article - 20/05/2009 One-sided diabetes debate – social issues not in the public domain Paediatrician and epidemiologist Reinhard Holl does not like exaggeration. He knows the real statistics only too well and, at the same time, is well aware how different statistics relating to diabetes in children and adolescents are “sold” to the public. Holl is head of the Computer-based Quality Management in Medicine workgroup at the Institute of Epidemiology at the University of Ulm. He has been collecting data on diabetes since 1995 and has…https://www.gesundheitsindustrie-bw.de/en/article/news/one-sided-diabetes-debate-social-issues-not-in-the-public-domain
Article - 19/05/2009 What makes blood vessels sprout? Calcified arteries or capillaries – this is often associated with blood stasis, reduced oxygen supply, and subsequent cardiac strain that compensates these deficiencies. Dr. Sebastian Grundmann from the Department of Cardiology and Angiology at the University Medical Centre Freiburg and his team are investigating how the growth of blood vessels is triggered, and potentially find ways to naturally deviate the site of congestion. https://www.gesundheitsindustrie-bw.de/en/article/news/what-makes-blood-vessels-sprout
Article - 18/05/2009 Less chemistry and fresher fruits and vegetables At Lake Constance fruit growers have bigger problems to face than ideological discussions on biotechnology and genetic engineering. They need methodological solutions for devastating plant diseases that would help them reduce the use of chemicals.https://www.biooekonomie-bw.de/en/articles/news/less-chemistry-and-fresher-fruits-and-vegetables
Article - 17/05/2009 What is a Mini GmbH? Can life science start-ups use this status? On November 1st 2008, a new law bringing significant change for limited liability companies (German GmbHs) in Germany was put into effect – Law for the Modernisation of the German Liability Company Law and the Prevention of Misuse (MoMiG; Gesetz zur Modernisierung des GmbH-Rechts und zur Bekämpfung von Missbräuchen). Under the new law, the new legal type of GmbH (UG – Unternehmergesellschaft) may be formed with share capital of just €1.…https://www.gesundheitsindustrie-bw.de/en/article/news/what-is-a-mini-gmbh-can-life-science-start-ups-use-this-status
Article - 16/05/2009 Mykotown Greentech AG uses mycorrhiza to keep plants going Mykotown Greentech AG offer mycorrhizal preparations that protect the plants against dehydration and bacteria. The fungi also enhance plant growth. The plants provide the natural soil fungi with carbon while the fungi help the plant to capture nutrients and liquids from the soil.https://www.gesundheitsindustrie-bw.de/en/article/news/mykotown-greentech-ag-uses-mycorrhiza-to-keep-plants-going
Article - 16/05/2009 Mykotown Greentech AG uses mycorrhiza to keep plants going Mykotown Greentech AG offer mycorrhizal preparations that protect the plants against dehydration and bacteria. The fungi also enhance plant growth. The plants provide the natural soil fungi with carbon while the fungi help the plant to capture nutrients and liquids from the soil.https://www.biooekonomie-bw.de/en/articles/news/mykotown-greentech-ag-uses-mycorrhiza-to-keep-plants-going
Article - 15/05/2009 Diabetes: we cannot wait any longer, we must act now! The renowned endocrinologist Prof. Bernhard Böhm from Ulm, like many of his colleagues, is of the opinion that diabetes is a problem that concerns society as a whole. The following interview with the head of endocrinology at the University Hospital of Ulm shows why the USA invests 50 times more money into diabetes research and Böhm tells us about the three wishes he would ask of a “diabetes fairy”.https://www.gesundheitsindustrie-bw.de/en/article/news/diabetes-we-cannot-wait-any-longer-we-must-act-now
Article - 15/05/2009 Interdisciplinarity starts with support and supervision As new General Manager the all-round talent Dr. Heike Brandstädter has taken the helm of the PhD Graduate School. Through her work at the crossroads of the humanities and natural sciences her particular aim is to lessen the burden on young researchers and increase their chances of success on the job market.https://www.gesundheitsindustrie-bw.de/en/article/news/interdisciplinarity-starts-with-support-and-supervision
Article - 14/05/2009 A multicentred approach for the treatment and prevention of diabetes In order to counteract the increase in the number of diabetics it is necessary to take into account the entire psychosocial environment of the patients states Prof. Dr. Peter Nawroth a physician from Heidelberg University Hospital. The prevention of late complications must be a major goal of any treatment and patient consultation. By focusing on the development and investigation of the RAGE-dependent reaction system Nawroth and his team have…https://www.gesundheitsindustrie-bw.de/en/article/news/a-multicentred-approach-for-the-treatment-and-prevention-of-diabetes
Press release - 14/05/2009 Mannheim University of Applied Sciences: scientists to receive start-up grant Dr. Heiko Flammann and Dr. Andreas Lux have received a one-year start-up grant from the German Ministry of Economics and Technology EXIST programme. The two scientists worked for many years at the Institute for Molecular and Cellular Biology (Head: Prof. Dr. Mathias Hafner) in the Faculty of Biotechnology at the Mannheim University of Applied Sciences.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mannheim-university-of-applied-sciences-scientists-to-receive-start-up-grant
Article - 13/05/2009 Mitochondria – making the impossible possible The transport of proteins across the two mitochondrial membranes is a very complex process. Huge molecular machines recognise the precursor proteins which are formed inside the cell and which are destined for the energy power stations of the cells. Some of these substances pass the outer and the inner membrane, some of them remain in the intermembrane area. How does the sorting of the molecules work? Five years ago, molecular biologist Dr.…https://www.gesundheitsindustrie-bw.de/en/article/news/mitochondria-making-the-impossible-possible
Press release - 12/05/2009 Gene variant responsible for defective communication in the brain Schizophrenia and bipolar disorder are psychological diseases that are both common and severe. The causes of these diseases are largely unknown. It has been known for some time that certain hereditary factors enhance the risk of developing schizophrenia or a manic-depressive disorder. Researchers from the ZI in Mannheim and the Department of Medicine Psychology at the University of Bonn have managed to identify the effects of such gene variants…https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-variant-responsible-for-defective-communication-in-the-brain